Coassembled Multicomponent Protein Nanoparticles Elicit Enhanced Antibacterial Activity

Area of Science:

• Nanotechnology
• Microbiology
• Drug Discovery

Background:

• The diminishing pipeline of effective antibiotics necessitates novel strategies against resistant pathogens, especially Gram-negative bacteria.
• Gram-negative bacteria possess a unique, impermeable cell envelope that poses a significant challenge for drug penetration.

Purpose of the Study:

• To develop multicomponent coassembled nanoparticles with enhanced bactericidal activity and simultaneous bacterial cell envelope targeting.
• To investigate the mechanisms underlying the superior performance of these coassembled nanoparticles.

Main Methods:

• Peptide coassembly strategy to create multicomponent nanoparticles.
• Confocal and electron microscopy to analyze nanoparticle interactions with bacterial cells.
• Evaluation of antibacterial activity against Gram-negative bacteria (Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli).

Main Results:

• Coassembled nanoparticles demonstrated significantly higher bacterial killing efficiency (100-1,000,000-fold increase) compared to single-component nanoparticles or mixtures.
• Mechanisms of action include membrane destabilization, disruption, and cell wall hydrolysis.
• No cytotoxic or hemolytic activity observed against eukaryotic cells and erythrocytes.

Conclusions:

• Multicomponent coassembled nanoparticles offer a potent strategy to overcome the Gram-negative bacterial barrier.
• The enhanced efficacy is attributed to optimized local concentration, high avidity, cooperativity, and synergy.
• This platform technology holds potential for developing new nano-antibacterials to address the antibiotic resistance crisis.